Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Asia 100: Operating Profit Returns To Asian Pharma Sector

Executive Summary

Scrip Asia 100 companies showed a return to greater operating profitability for financial year 2015 despite reduced overall dollar-denominated pharmaceutical sales.

Advertisement

Related Content

China Growth Rebounds But Pharma Starts Cutting Prices
Asia-Pacific Healthcare Investment Solid Despite Global Worries
One To Watch: Chi-Med Approaches Inflection Points
A Peek Into Korean Bioventures’ Success Factors, Challenges
What Did Big Pharma Earnings Say About China Growth?

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register